Accessibility Menu
 

Why Pacira Pharmaceuticals Shot Higher Last Month

Better growth than was expected caused shares in this maker of post-surgical painkillers to soar in October.

By Todd Campbell Updated Nov 17, 2015 at 8:00AM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.